Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90ba549cf5d8907a4958d5e096f2f4f4 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C401-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08 |
filingDate |
1997-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c015f6f6a287494afb1de5de947166b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d23bdc1f3c9ede29a535a2924cd7518e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca5e78388fa83403ca45b491ea013b6f |
publicationDate |
2000-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CZ-235599-A3 |
titleOfInvention |
Inhibition of hyperproliferative activity of neoplastic or hyperplastic human prostate cells and a pharmaceutical composition for this purpose |
abstract |
Ια-hydroxyvitamin D compound substitutednat position C24 by a hydrocarbon group for use for inhibitionnhyperproliferative activities of neoplastic ornhuman prostate hyperplastic cells and pharmaceuticalna composition based thereon |
priorityDate |
1997-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |